Nepal’s rabies vaccine crisis puts lives on the line

Nepal is grappling with a severe shortage of rabies vaccines, leaving state-run health facilities unable to provide the life-saving jabs. Even the Sukraraj Tropical and Infectious Hospital, the country's primary rabies treatment center, is running critically low on stock, with its current supply expected to last only a few days. With over 500 people seeking vaccination daily, this shortage could rapidly escalate into a public health emergency, particularly impacting those who cannot afford private clinic costs.

The Epidemiology and Disease Control Division, responsible for vaccine supply, has abandoned its procurement efforts after repeated failures. It has now tasked provincial health agencies and local authorities with acquiring the vaccines independently, a move that offers little immediate relief. This crisis is not new, having persisted since last year without adequate urgency from authorities. Despite significant government allocations for vaccine purchases in the current and upcoming fiscal years, timely procurement has failed, exposing a critical lack of preparedness within the healthcare system.

This recurring vaccine shortage, which also affects other essential vaccines like those for measles, underscores deep-seated problems within Nepal's healthcare infrastructure. Bureaucratic delays and procurement failures should not lead to stockouts of essential, life-saving vaccines. The situation not only undermines the constitutional right to health for Nepali citizens but also jeopardizes the nation's goal, aligned with the WHO, to eliminate dog-transmitted rabies by 2030. The financial burden of seeking treatment in private clinics further deters timely intervention for many.